Literature DB >> 3073448

Immunoregulatory cells in human decidua: morphology, immunohistochemistry and function.

J N Bulmer1, D Pace, A Ritson.   

Abstract

Suggestions that local intrauterine materno-fetal immune interactions may be important for normal pregnancy have led to investigation of immunoregulatory function by decidualised endometrium. Human decidua is complex and cell types may be difficult to distinguish at the light microscope level. Immunohistochemical techniques have allowed antigenic identification of cells within decidua and abundant leucocytes are present throughout pregnancy. Macrophages (CD14+) are abundant in decidua basalis and decidua parietalis throughout pregnancy and may be closely associated with extravillous trophoblast. Expression of class II MHC antigens and CD11c may suggest an immunological role but their content of lysosomal enzymes could indicate phagocytic functions. Antigen-presenting capacity has been noted in early human decidua and may be due to macrophages. Decidual macrophages have also been attributed with immunosuppressive function due to secretion of prostaglandin E2. Decidual granulated lymphocytes are abundant in the first trimester and correspond to the so-called endometrial stromal granulocytes. They express CD2, CD7, CD38 and NKH1 but are negative for classical T cell and NK cell markers and they do not express the IL2 receptor. Semipurified populations show low levels of cytotoxicity in a standard NK assay. Thus, immunohistochemical techniques have allowed characterisation of potentially immunocompetent cells in human decidua. However, their roles both in vitro and in vivo remain to be established with certainty.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3073448     DOI: 10.1051/rnd:19881006

Source DB:  PubMed          Journal:  Reprod Nutr Dev        ISSN: 0181-1916


  34 in total

1.  Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy.

Authors:  Ulrike Kämmerer; Andreas O Eggert; Michaela Kapp; Alexander D McLellan; Teunis B H Geijtenbeek; Johannes Dietl; Yvette van Kooyk; Eckhart Kämpgen
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  Stranger in a strange land.

Authors:  Joan S Hunt
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 3.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

4.  A comparison of two populations of decidual cells by immunocytochemistry and prostaglandin production.

Authors:  H Khan; O Ishihara; M G Elder; M H Sullivan
Journal:  Histochemistry       Date:  1991

5.  Allergy-induced preterm labor after the ingestion of shellfish.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Hernan Muñoz; Ricardo Gomez; Ronald F Lamont; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2010-04

6.  The unique immunological and microbial aspects of pregnancy.

Authors:  Gil Mor; Paulomi Aldo; Ayesha B Alvero
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

Review 7.  Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders.

Authors:  Kaori Koga; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2010-03-29       Impact factor: 3.886

Review 8.  The immune system in pregnancy: a unique complexity.

Authors:  Gil Mor; Ingrid Cardenas
Journal:  Am J Reprod Immunol       Date:  2010-03-29       Impact factor: 3.886

Review 9.  Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis.

Authors:  Fernando M Reis; Felice Petraglia; Robert N Taylor
Journal:  Hum Reprod Update       Date:  2013-03-28       Impact factor: 15.610

10.  Trophoblast induces monocyte differentiation into CD14+/CD16+ macrophages.

Authors:  Paulomi B Aldo; Karen Racicot; Vinicius Craviero; Seth Guller; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-07-03       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.